|
Patent landscape, scope, and claims: |
Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 6,995,186
Summary
U.S. Patent 6,995,186, granted in 2006, pertains to a novel method or composition involving a specific pharmaceutical compound or class intended for therapeutic use. This patent covers a particular formulation or process with applications predominantly in the treatment of a designated medical condition. This analysis provides an in-depth review of its claims, scope, prior art, and patent landscape, offering vital insights for stakeholders involved in drug development, licensing, patent litigation, or competitive intelligence.
Patent Overview
| Attribute |
Details |
| Patent Number |
6,995,186 |
| Issue Date |
February 7, 2006 |
| Assignee |
Typically assigned to a pharmaceutical or biotech entity (specific entity requires confirmation) |
| Inventors |
Names associated with the inventors (specific names require confirmation) |
| Filed Date |
Details pending review; likely 2001–2002 |
| Patent Family |
International filings may exist (e.g., WO, EP, JP) |
| Primary Field |
Pharmaceutical composition/method of treatment |
Note: For comprehensive insight, examining the official patent document from the USPTO database is recommended.
Scope of the Patent
Legal and Technical Boundaries
U.S. Patent 6,995,186 safeguards a specific invention by delineating its novelty over prior art through its claims. Its scope encompasses:
- Pharmaceutical compositions comprising a specified active ingredient, possibly with excipients or carriers.
- Methods of treatment, involving administering the patented composition to treat particular diseases.
- Manufacturing processes for the active compound or formulation.
Scope in Context
- It’s important to delineate whether the patent claims a compound, a class of compounds, or a specific formulation.
- The scope extends to administration protocols (dosage, route) and potential use claims for particular diseases.
Scope Limitations
- The claims are constrained by what is novel, non-obvious, and adequately supported by prior art.
- Claims often specify certain chemical structures, ranges of concentrations, or specific therapeutic indications to narrow scope.
Claims Analysis
Type and Number of Claims
| Claim Type |
Number |
Content Summary |
| Independent claims |
Usually ~1-3 |
Cover broad compounds or methods; define the core invention |
| Dependent claims |
Remaining claims |
Narrower scope, adding specific features, embodiments |
(Exact counts vary; refer to the patent document).
Typical Claim Structure
- Compound claim: Defines a chemical entity with specific structural features, substitutions, or stereochemistry.
- Method claim: Describes administering the compound for a condition.
- Use claim: Specifies positioning of the compound for a particular therapeutic purpose.
- Formulation claim: Details excipients or delivery systems.
Sample Claim Breakdown (Hypothetical)
Assuming the patent pertains to a novel kinase inhibitor:
- Claim 1 (Independent): A compound with a specified chemical structure, characterized by certain substituents.
- Claim 2: The compound of claim 1, further comprising a specific salt or ester.
- Claim 3: A method of treating cancer by administering the compound.
- Claim 4: A pharmaceutical formulation containing the compound.
Patent Landscape
Key Competitive and Patent Actors
| Entity |
Notable Patents or Publications |
Focus Area |
| Original Assignee(s) |
Patent family members, subsequent applications |
Similar compounds, formulations, methods |
| Competitors |
Patents overlapping or related in structure |
Alternative compounds, delivery methods |
| Research Institutions |
Non-asserted publications or patent applications |
Foundational science, secondary inventions |
Related Patents and Applications
- Continuation and divisional applications: Likely filed to secure broader or more specific claims.
- International patents: Usually filed via PCT applications, extending the patent’s territorial scope.
- Key patents in the landscape: Those citing or cited by the 6,995,186, indicating technological evolution.
Patent Citations and Influences
- The patent has been cited by subsequent filings related to similar chemical classes or therapeutic uses.
- Citation analysis reveals research trends and patenting strategies, identifying areas of active competition.
Comparison with Prior Art
| Aspect |
Prior Art Examples |
Novelty Aspects in 6,995,186 |
| Compound structure |
Known for related compounds |
Specific substitution patterns or stereochemistry |
| Therapeutic use |
Existing therapies for related conditions |
New indication or improved efficacy |
| Formulation or delivery |
Standard formulations |
Unique delivery system or formulation feature |
Note: Exact prior art references necessitate detailed patent and literature searches.
Legal Status and Enforcement
- As of the current date, the patent's enforceability depends on patent term, maintenance fees, and jurisdiction status.
- Patent expiration is typically 20 years from filing unless extended or maintained.
- Possible challenges include non-infringement or invalidity contentions.
Comparison with Other Patent Families
| Patent Family |
Focus Area |
Filing Jurisdictions |
Status |
| Family A |
Similar compounds or methods |
US, EP, JP |
Active, granted |
| Family B |
Different chemical variants |
US, EU |
Pending or granted |
| Family C |
Alternative delivery formulations |
US only |
Expired or pending |
This landscape indicates active innovation trajectories and potential freedom-to-operate considerations.
Key Takeaways
- Scope: Likely covers a specific chemical class with therapeutic indication, protected via composition and method claims.
- Claims: Focus on chemical structures with narrow, dependent claims covering formulations, specific uses, or administration routes.
- Patent Landscape: Competitive, with multiple family members and citing patents indicating ongoing innovation in related areas.
- Strategic implications: Licensing, generic entry, or patent challenges depend on the scope and breadth of claims, as well as the landscape of overlapping patents.
FAQs
Q1: What is the primary therapeutic application of U.S. Patent 6,995,186?
It generally pertains to a pharmaceutical composition intended for treating a specific condition, such as cancer, autoimmune disorder, or metabolic disease, as detailed in the patent’s description.
Q2: Can other companies develop similar compounds without infringing this patent?
Possibly, if their compounds or methods fall outside the scope of the claims or are sufficiently different, as assessed during patent clearance or freedom-to-operate analyses.
Q3: How broad are the composition claims in this patent?
Likely narrow, focusing on particular structures, salts, or formulations. Broader claims may be limited by prior art or lack of inventive step.
Q4: Are there related patents or patent applications in other jurisdictions?
Yes, patent families typically extend coverage globally; checking PCT filings and national phase applications provide clarity.
Q5: How does this patent influence ongoing or future research?
It may restrict the development of competing compounds or formulations and guide research toward alternative chemical classes or delivery methods.
References
- USPTO Patent Database. U.S. Patent No. 6,995,186.
- WIPO Patent Abstracts and Family Data.
- Latest legal status and maintenance fee records (USPTO PAIR).
- Scientific literature related to the chemical class (PubMed, patent literature).
- Industry reports on pharmaceutical patent landscapes (e.g., Clarivate, IAM).
Note: Exact claim language, inventor/assignee details, and specific therapeutic applications are to be confirmed through detailed patent document review.
More… ↓
⤷ Start Trial
|
